This surgical procedure is used for rectal carcinomas that, in terms of height localization by rigid rectoscopy, can be resected with a safety margin of 1 – 2 cm to the linea dentata measured from the lower tumor edge.
For rectal carcinomas where this safety margin cannot be maintained or where the sphincter is additionally infiltrated, abdominoperineal rectal extirpation is indicated. For early carcinomas (clinical category T1, N0, G1 or G2), local excision can be performed as an alternative to anterior rectal resection in accordance with guidelines.
Depending on the height of the anastomosis above the sphincter, the reconstruction after anterior or low anterior rectal resection can be performed as colorectal, coloanal, or colo-pouch-anal anastomosis.
Through the establishment of total mesorectal excision (TME) as the gold standard for tumors of the middle and lower third, the local recurrence rate could be reduced to below 10%.
In the example shown, it is a carcinoma of the middle rectal third (uT3,uN1). Therefore, neoadjuvant radiochemotherapy was performed in accordance with guidelines. After re-staging, which showed no evidence of distant metastasis, the indication for oncological tumor resection was established.
Neoadjuvant Radiotherapy
Neoadjuvant radiotherapy can be administered with or without chemotherapy and is recommended according to S3 guidelines for rectal carcinoma in UICC stages II (pT3-4 pN0) and III (pT1-4 pN+).
Neoadjuvant radiochemotherapy (RCT) lasts about 6 weeks, followed by a treatment break of 6-8 weeks until surgery.
Neoadjuvant short-term irradiation (RT) is administered on 5 consecutive days. Here, surgery follows after 2-7 days. Since tumor downsizing is not expected, RCT is preferred for tumors that reach the enveloping fascia or are located close to the sphincter.
27% of patients show histological complete remission through RCT. These patients have a particularly good oncological prognosis. Since response assessment is difficult and requires DRE (digital rectal examination), endoscopy, and MRI for detection, a “watch-and-wait” strategy can only be applied to tumors up to 7 cm from the anus and preferably in studies.

